C-H vs C-C bond activation of acetonitrile and benzonitrile via oxidative addition: rhodium vs nickel and Cp* vs Tp' (Tp' = hydrotris(3,5-dimethylpyrazol-1-yl)borate, Cp* = η(5)-pentamethylcyclopentadienyl)

The photochemical reaction of (C(5)Me(5))Rh(PMe(3))H(2) (1) in neat acetonitrile leads to formation of the C-H activation product, (C(5)Me(5))Rh(PMe(3))(CH(2)CN)H (2). Thermolysis of this product in acetonitrile or benzene leads to thermal rearrangement to the C-C activation product, (C(5)Me(5))Rh(PMe(3))(CH(3))(CN) (4). Similar results were observed for the reaction of 1 with benzonitrile. The photolysis of 1 in neat benzonitrile results in C-H activation at the ortho, meta, and para positions. Thermolysis of the mixture in neat benzonitrile results in clean conversion to the C-C activation product, (C(5)Me(5))Rh(PMe(3))(C(6)H(5))(CN) (5). DFT calculations on the acetonitrile system show the barrier to C-H activation to be 4.3 kcal mol(-1) lower than the barrier to C-C activation. A high-energy intermediate was also located and found to connect the transition states leading to C-H and C-C activation. This intermediate has an agostic hydrogen interaction with the rhodium center. Reactions of acetonitrile and benzonitrile with the fragment [Tp'Rh(CNneopentyl)] show only C-H and no C-C activation. These reactions with rhodium are compared and contrasted to related reactions with [Ni(dippe)H](2), which show only C-CN bond cleavage.     

An anionic, tetragonal copper(II) superoxide complex

Insight into copper-oxygen species proposed as intermediates in oxidation catalysis is provided by the identification of a Cu(II)-superoxide complex supported by a sterically hindered, pyridinedicarboxamide ligand. A tetragonal, end-on superoxide structure is proposed based on DFT calculations and UV-vis, NMR, EPR, and resonance Raman spectroscopy. The complex yields a trans-1,2-peroxodicopper(II) species upon reaction with [(tmpa)Cu(CH(3)CN)]OTf and, unlike other known Cu(II)-superoxide complexes, acts as a base rather than an electrophilic (H-atom abstracting) reagent in reactions with phenols.     

Computational design of a self-assembling β-peptide oligomer

The first computationally designed self-assembling oligomer consisting of exclusively β-amino acids (βAAs) is presented. The packing of a β-3(14) helix into coiled-coils of varying stoichiometries as a function of amino acid sequence is examined. β-Peptides with hVal repeating every third residue in the sequence appeared to have a strong propensity to pack into hexameric bundles. The designed sequence was synthesized and characterized with CD spectroscopy, NMR, and analytical ultracentrifugation, suggesting that the peptide adopts a well-folded hexameric structure.     

Stereoselective Control by Face‐to‐Face Versus Edge‐to‐Face Aromatic Interactions: The Case of C3‐TiIV Amino Trialkolate Sulfoxidation Catalysts

The stereoselective oxidation of differently functionalised benzyl phenyl sulfides has been examined by using enantiopure Ti^IV trialkanolamine complexes. These complexes efficiently catalyse the sulfoxidation with good stereoselectivities. The data highlight the contribution to the stereoselectivity of steric effects and non‐covalent π–π interactions between the aromatic rings of the Ti^IV complex and those pertaining to the substrates. Enantiomeric excesses have been correlated with the electrostatic potential surfaces (EPS) of the reacting sulfides. The overall study leads to a mechanistic interpretation that explains the stereoselectivity of the system and dissects the role of aromatic and steric interactions in the stereoselective process.     

Determination of 3',4',5',5,7-pentamethoxyflavone in the plasma and intestinal mucosa of mice by HPLC with UV detection

In a preliminary experiment 3',4',5',5,7-pentamethoxyflavone (PMF) inhibited adenoma development in Apc(Min) mice, a model of the human heritable condition familial adenomatous polyposis. An HPLC method for tricin was modified and validated to permit measurement of PMF in mouse plasma and intestinal mucosa. HPLC analysis was carried out on a Hypersil-BDS C(18) column with detection at 324 nm and tricin as internal standard. The assay was linear in the range of 100-2000 ng/mL plasma and 1.0-40 microg/mL mucosa. PMF in plasma was efficiently extracted using solid-phase columns. In the case of mucosa organic solvent protein precipitation displayed satisfactory accuracy and precision. The assay recovery at low, medium and high concentrations was between 85 and 103% for both biomatrices, with a relative standard deviation of <15%. The lower limits of quantitation for plasma and mucosa were 100 ng/mL and 1.0 microg/mL, respectively. This method allowed measurement of PMF steady-state median concentrations in plasma (1.08 nmol/mL, n = 11; 10th and 90th percentiles: 0.633 and 2.385 nmol/mL) and mucosa (108.5 nmol/g, n = 9; 10th and 90th percentiles: 38.9 and 164.4 nmol/g) in mice which had received PMF (0.2%, w/w) with their diet.     

Synthesis of a tetraoxy-bis-nortaxadiene, en route to taxol, using a cascade radical cyclisation sequence

Concise syntheses of the substituted enynediones 28a, 33b and 36 starting from the cyclohexenealdehyde 18, corresponding to ring A in the taxanes, and the vinylstannane 24, are described. Treatment of 36 with Bu₃SnH-AIBN did not lead to the oxy-substituted taxadiene 37 expected from a tandem radical macrocyclisation-radical transannulation sequence; instead, a mixture of unidentified products resulted. When the PMB ether 33b corresponding to the alcohol 36 was treated with Bu₃SnH-AIBN under similar conditions, p-anisaldehyde was isolated, as a major by-product, but no evidence for the formation of a taxadiene could be observed. In contrast, the iododienynedione 41, i.e., deoxy 36, underwent a tandem radical macrocyclisation-transannulation sequence, when treated with Bu₃SnH-AIBN, leading to the tetraoxy-bis-nortaxadiene 42 in 44% yield. Attempts to synthesise the alcohol 28b from the silyl ether 28a en route to the iodide 28c instead gave the substituted tetrahydrofuran 29 via an intramolecular oxy-Michael reaction.     

Homo-timeric structural model of human microsomal prostaglandin E synthase-1 and characterization of its substrate/inhibitor binding interactions

Inducible, microsomal prostaglandin E synthase 1 (mPGES-1), the terminal enzyme in the prostaglandin (PG) biosynthetic pathway, constitutes a promising therapeutic target for the development of new anti-inflammatory drugs. To elucidate structure–function relationships and to enable structure-based design, an mPGES-1 homology model was developed using the three-dimensional structure of the closest homologue of the MAPEG family (Membrane Associated Proteins in Eicosanoid and Glutathione metabolism), mGST-1. The ensuing model of mPGES-1 is a homo-trimer, with each monomer consisting of four membrane-spanning segments. Extensive structure refinement revealed an inter-monomer salt bridge (K26-E77) as well as inter-helical interactions within each monomer, including polar hydrogen bonds (e.g. T78-R110-T129) and hydrophobic π-stacking (F82-F103-F106), all contributing to the overall stability of the homo-trimer of mPGES-1. Catalytic co-factor glutathione (GSH) was docked into the mPGES-1 model by flexible optimization of both the ligand and the protein conformations, starting from the initial location ascertained from the mGST-1 structure. Possible binding site for the substrate, prostaglandin H₂ (PGH₂), was identified by systematically probing the refined molecular structure of mPGES-1. A binding model was generated by induced fit docking of PGH₂ in the presence of GSH. The homology model prescribes three potential inhibitor binding sites per mPGES-1 trimer. This was further confirmed experimentally by equilibrium dialysis study which generated a binding stoichiometric ratio of approximately three inhibitor molecules to three mPGES-1 monomers. The structural model that we have derived could serve as a useful tool for structure-guided design of inhibitors for this emergently important therapeutic target.     

Using the solvation parameter model to characterize functionalized ionic liquids containing the tris(pentafluoroethyl)trifluorophosphate (FAP) anion

Ionic liquids (ILs) containing the tris(pentafluoroethyl)trifluorophosphate anion [FAP]⁻ have attracted increased attention due to their unique properties including ultrahigh hydrophobicity, hydrolytic stability, and wide electrochemical window. In this study, the solvation parameter model is used via gas chromatography to characterize the solvation interactions of seven ILs containing amino, ester, and hydroxyl functional groups appended to the cation and paired with [FAP]⁻, as well as three ILs containing the bis[(trifluoromethyl)sulfonyl]imide anion [NTf₂]⁻. The role of the functional groups, nature of the counter anion, and cation type on the system constants were evaluated. ILs containing [FAP]⁻ possessed lower hydrogen bond basicity than NTf₂-based ILs having the same cationic component; in the case of hydroxyl-functionalized cations, the presence of [FAP]⁻ led to an enhancement of the hydrogen bond acidity, relative to the NTf₂-analogs. The system constants support the argument that [FAP]⁻ weakly coordinates the cation and any appended functional groups, promoting properties of the cation which might be masked by stronger interactions with other anion systems. The chromatographic performance of the IL stationary phases was evaluated by examining the retention behavior and separation selectivity for chosen analytes. The results from this work can be used as a guide for choosing FAP-based ILs capable of exhibiting desired solvation properties while retaining important physical properties including high thermal stability and high hydrophobicity. Figure In this study, the solvation parameter model is used via gas chromatography to characterize the solvation interactions of seven ILs containing amino, ester, and hydroxyl functional groups appended to the cation and paired with tris(pentafluoroethyl)trifluorophosphate [FAP]⁻, as well as three ILs containing the bis[(trifluoromethyl)sulfonyl]imide anion [NTf₂]⁻. Electronic supplementary material  The online version of this article (doi:) contains supplementary material, which is available to authorized users.     

Photocytotoxicity of the Fluorescent Nonsteroidal Androgen Receptor Ligand TDPQ†

1,2,3,4‐tetrahydro‐2,2‐dimethyl‐6‐(trifluoromethyl)‐8‐pyridono[5,6‐g]quinoline (TDPQ), a selective nonsteroidal androgen receptor (AR) ligand, is a fluorescent compound. We characterized its spectral properties in comparison with the structural precursor carbostyril 151 (C151) and with its racemic structural isomer 4‐ethyl‐1,2,3,4‐tetrahydro‐6‐(trifluoromethyl)‐8‐pyridino[5,6‐g]quinoline (ETPQ). The absorption maximum in CH₃CN of either TDPQ or ETPQ is 400 nm whereas that of C151 is 350 nm. The fluorescence lifetimes (τ) and quantum yields (?_f) in CH₃CN are typical of fluorescent dyes: TDPQ (4.2 ns, 0.8) and ETPQ (4.6 ns, 0.76). C151 showed lower τ and ?_f of 0.2 ns and 0.02, respectively. TDPQ can function as a fluorescent label at (sub)micromolar concentrations. We detected TDPQ fluorescence in human breast tumor cells using confocal microscopy. While the fluorescence maxima of the compounds were solvent insensitive, the ?_f for ETPQ decreased in aqueous solutions regardless of the presence of albumin or DNA. The ?_f of TDPQ was less affected. The quantum yield of singlet oxygen (¹O₂) photosensitization (?_so) by TDPQ and ETPQ was about 7% in CH₃CN, sufficient to induce photocytotoxicity. TDPQ was photocytotoxic in AR‐positive MDA‐MB‐453 breast cancer cells but not in AR‐negative MDA‐MB‐231 cells. The combination of AR selectivity with photocytotoxicity makes TDPQ a promising candidate for selective targeting of AR‐positive cells during photodynamic therapy.     

A diketiminate‐bound diiron complex with a bridging carbonate ligand

Reduction of carbon dioxide by a diiron(I) complex gives μ‐carbonato‐κ³O:O′,O′′‐bis{[2,2,6,6‐tetramethyl‐3,5‐bis(2,4,6‐triisopropylphenyl)heptane‐2,5‐diiminate(1−)‐κ²N,N′]iron(II)} toluene disolvate, [Fe₂(C₄₁H₆₅N)₂(CO₃)]·2C₇H₈, a diiron(II) species with a bridging carbonate ligand. The asymmetric unit contains one diiron complex and two cocrystallized toluene solvent molecules that are distributed over three sites, one with atoms in general positions and two in crystallographic sites. Both Fe^II atoms are η²‐coordinated to diketiminate ligands, but η¹‐ and η²‐coordinated to the bridging carbonate ligand. Thus, one Fe^II center is three‐coordinate and the other is four‐coordinate. The bridging carbonate ligand is nearly perpendicular to the iron–diketiminate plane of the four‐coordinate Fe^II center and parallel to the plane of the three‐coordinate Fe^II center.